Research Papers:
Spatiotemporal control of gene expression in bone-marrow derived cells of the tumor microenvironment induced by MRI guided focused ultrasound
Metrics: PDF 1458 views | HTML 1843 views | ?
Abstract
Pierre-Yves Fortin1,2, Matthieu Lepetit-Coiffé1, Coralie Genevois1,2, Christelle Debeissat1, Bruno Quesson1, Chrit T.W. Moonen1, Jan Pieter Konsman3, Franck Couillaud1,3
1Laboratoire d’Imagerie Moléculaire et Fonctionnelle (IMF), CNRS/UMR 5231, Université de Bordeaux, Bordeaux, France
2Institut de Bio-Imagerie (IBIO), CNRS/UMS 3428, Université de Bordeaux, Bordeaux, France
3Centre de Résonance Magnétique des Systèmes Biologiques (RMSB), CNRS/UMR 5536, Université de Bordeaux, Bordeaux, France
Correspondence to:
Franck Couillaud, e-mail: [email protected]
Keywords: molecular imaging, gene therapy, cancer
Received: May 19, 2015 Accepted: June 02, 2015 Published: June 15, 2015
ABSTRACT
The tumor microenvironment is an interesting target for anticancer therapies but modifying this compartment is challenging. Here, we demonstrate the feasibility of a gene therapy strategy that combined targeting to bone marrow-derived tumor microenvironment using genetically modified bone-marrow derived cells and control of transgene expression by local hyperthermia through a thermo-inducible promoter. Chimera were obtained by engraftment of bone marrow from transgenic mice expressing reporter genes under transcriptional control of heat shock promoter and inoculated sub-cutaneously with tumors cells. Heat shocks were applied at the tumor site using a water bath or magnetic resonance guided high intensity focused ultrasound device. Reporter gene expression was followed by bioluminescence and fluorescence imaging and immunohistochemistry. Bone marrow-derived cells expressing reporter genes were identified to be mainly tumor-associated macrophages. We thus provide the proof of concept for a gene therapy strategy that allows for spatiotemporal control of transgenes expression by macrophages targeted to the tumor microenvironment.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 4288